contents

america
 

Genomic Health presents at San Antonio Breast Cancer Symposium

Genomic Health, Inc. announced that the company will present results from five studies at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), taking place December 9-13, 2009, at the Henry B. Gonzalez Convention Center. Four of the studies analyze Oncotype DX, the company's multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit as well as the likelihood of recurrence for women with early-stage breast cancer.



write your comments about the article :: 2009 Exhibition News :: home page